Please provide a rationale and justification for the rating.
NACOSA received the following formal ratings by the GFATM:
-
First 8-month grant (SAF-910-G08-H) A1 rating
-
SSF grant; up to June 2012 A2 rating
-
SSF grant; up to Sep 2012 A1 rating
For the period October to December 2012 NACOSA’s performance stayed on par (please refer Section 5.1.1 above). NACOSA received its final disbursement for the period ending March 2013. NACOSA also submitted its PUDR for the period on time.
5.2 Financial Performance | 5.2.1 Financial situation at cut-off date |
Cash at cut-off date
Have all liabilities at cut-off date been taken into account in the post-cut-off date budget? Yes
All liabilities at the end of September 2012 were provided to the GF in a PR Forecast template to be spent by the 31 March 2013. The PR has received their final disbursement up to end March 2013.
5.2.2 Analysis of expenditures versus budget
|
With reference to the latest available EFR at cut-off date, please summarize the main reasons for any under-spending or over-spending against budget.
NACOSA submitted their latest Performance Update (“PU”) for the cut-off date on 15th February 2013, and the main reasons for any budget variances explained in the PU is highlighted below as per the relevant or affected Cost Categories:
Human Resources
There was under-spend and savings to the grant as some staff posts were filled later than anticipated, and there were delays in the replacements of vacancies.
One of NACOSA’s National Sub-Recipients was under-spent with regard to the number of hours worked by GPs at Public Health Sites for ARV support. Doctors were seeing more clients per hour than originally estimated.
Health Products and Equipment
Due to a GF instruction in December 2011 to cease procurement of the SD Bioline Rapid Tests, some Sub-Recipients did not procure HCT test kits as planned during the grant period. However, gloves, alcohol swabs and lancets were purchased during the reporting period.
As a result of the above, some Sub-Recipients obtained their kits from the Department of Health and did not use all the funding allocation.
As mentioned above in the programmatic performance of NACOSA, NACOSA has 11 achieved out of 13 performance indicators as contained in the Performance Framework:
-
80% target achieved for: Number of targeted audience reached through BCC. The expenditure is in line with the target achieved
-
89% target achieved for: Number of community organisations that received capacity building to assist PLWHIV. The expenditure is in line with the target achieved.
-
There has been some savings in Human Resources as mentioned above, but overall the expenditure matches the targets achieved.
NACOSA is in the process of preparing their EFR and more information will be provided once this has been completed
SECTION 6: CCM REQUEST FOR RENEWAL (PR 3 – NACOSA) | 6.1 Programmatic Proposal | 6.1.1 Programme Objectives, SDAs, Indicators and Targets |
Table 36: Performance Framework NACOSA
Objective & Indicator Number
|
Service Delivery Area
|
Output/coverage indicator
|
Latest available baseline/result
|
Targets
|
Period 1
|
Period 2
|
Period 3
|
Period 4
|
Period 5
|
N #
|
%
|
Year
|
Source
|
1-Oct-13
|
1-Apr-14
|
1-Oct-14
|
1-Apr-15
|
1-Oct-15
|
D #
|
31-Mar-14
|
30-Sep-14
|
31-Mar-15
|
30-Sep-15
|
31-Mar-16
|
OBJ 1: OP101
|
Prevention - GBV
|
Number of sexual violence victims who received services at the Thuthuzela Care Centres
|
TBD
######
|
2013
|
PR Results
|
11 100
|
67.0%
|
22 200
|
65.4%
|
33 300
|
64.9%
|
44 400
|
63.8%
|
55 500
|
63.2%
|
16 560
|
33 948
|
51 336
|
69 593
|
87 850
|
OBJ 1: OP101
|
Prevention - GBV
|
% of sexual violence victims who received services at the Thuthuzela Care Centres who then report the matter to the police
|
TBD
|
|
PR Results
|
9 990
|
90.0%
|
19 980
|
90.0%
|
29 970
|
90.0%
|
39 960
|
90.0%
|
49 950
|
90.0%
|
2013
|
11 100
|
22 200
|
33 300
|
44 400
|
55 500
|
OBJ 1: OP102
|
OVC care and support
|
Number and percentage of OVC that received services and received an HIV test and know the result
|
TBD
|
2013
|
PR Results
|
950
|
5.4%
|
2 850
|
16.3%
|
4 750
|
27.1%
|
6 650
|
38.0%
|
8 550
|
48.9%
|
17 500
|
17 500
|
17 500
|
17 500
|
17 500
|
OBJ 1: OP103
|
OVC care and support
|
Number & % of OVC aged 0–17 years whose households received free basic external support in caring for the child
|
10628
|
TBD
|
2012
|
PR Results
|
26 273
|
TBD
|
29 630
|
TBD
|
34 265
|
TBD
|
37 259
|
TBD
|
33 536
|
TBD
|
TBD
|
TBD
|
TBD
|
TBD
|
TBD
|
TBD
|
OBJ 2: OP104
|
Prevention - Sex workers
|
Number of individuals from key populations (sex workers) reached with HIV prevention combination package
|
TBD
|
2013
|
PR Results
|
15 000
|
9.8%
|
33 600
|
22.0%
|
33 600
|
22.0%
|
33 600
|
22.0%
|
33 600
|
|
153 000
|
153 000
|
153 000
|
153 000
|
153 000
|
|
OBJ 2: OP105
|
Prevention - Sex workers
|
Number & Percentage from key populations (Sex workers) who received an HIV test in the last 12 months & know their tes
|
TBD
|
2013
|
PR Results
|
585
|
7.8%
|
5 040
|
30%
|
11 341
|
67.5%
|
14 712
|
87.6%
|
16 800
|
100%
|
7 500
|
16 800
|
16 800
|
16 800
|
16 800
|
OBJ 2: OP107
|
Prevention - Low socio-economic
|
Number & Percentage from key populations (Low socio-economic) who received an HIV test in the last 12 months & know their test results
|
TBD
|
2013
|
PR Results
|
101 556
|
#NA E!
|
243 288
|
NA ALUE!
|
425 196
|
#V NA ALUE!
|
607 104
|
#VAL NA UE!
|
789 012
|
#VALU NA E!
|
NA
|
NA
|
NA
|
NA
|
NA
|
OBJ 2: OP108
|
Prevention - MSM
|
Number of individuals from key populations (MSM) reached with HIV prevention combination package
|
TBD
|
2013
|
PR Results
|
860
|
TB TB NA D
|
15 470
|
NA
|
20 626
|
NA
|
20 626
|
NA
|
22 345
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
OBJ 2: OP109
|
Prevention - MSM
|
Number & Percentage from key populations (MSM) who received an HIV test in the last 12 months & know their test results
|
TBD
|
2013
|
PR Results
|
185
|
2NA21.5%1.5%
|
7 218
|
46.7%
|
12 812
|
62.1%
|
16781
|
81.4%
|
19427
|
86.9%
|
860
|
15 470
|
20 626
|
20 626
|
22 345
|
OBJ 2:OP 114
|
Prevention- Youth
|
Number of female learners on Grades 7-9 reached with an HIV combination prevention package.
|
N/A
|
0
|
0%
|
4 500
|
2.8%
|
16 500
|
10.4%
|
31 000
|
19.5%
|
40 000
|
25.2%
|
158 952
|
158 952
|
158 952
|
158 952
|
158 952
|
OBJ 3: OP115
|
Care and support for chronically ill
|
Number of people living with HIV/TB reached with adherencesessions –
|
TBD
|
2013
|
PR Results
|
78 600
|
NA
|
76 868
|
NA
|
76 868
|
NA
|
75 132
|
NA
|
75 132
|
NA
|
NA
|
NA
|
NA
|
NA
|
|
The detail on the Objectives, SDAs and Activities can be found as the NACOSA Annex 1 called Description of Activities– NACOSA. During the development of the Performance Framework all indicators and targets were aligned with the NSP, other national programme strategies, plans and systems.
6.1.2 Pharmaceutical and Health Product Management (if applicable) |
Dostları ilə paylaş: |
